Apparently, in the USA – and soon in all other countries – new sanctions and rules will be introduced for the creation, packaging and sale of medicines, since today very eloquent results of one study by pharmaceutical specialists from the Massachusetts Technical University were presented. The study addresses the question of whether the so-called “inactive ingredients” in drugs are actually safe for most patients — their results showed that in the world of modern pharmaceuticals, everything can be much more complicated and diverse than it is on the package of a drug.
In particular, the study focused on the consideration of certain individual static and inactive ingredients – in particular, gluten and fructose, which are commonly used to increase the life cycle of a drug and improve its chemical stability. The study was conducted in relation to many categories of patients using different drugs, and its results demonstrated that for some patients with a predisposition, sensitivity or an allergic reaction to certain inactive components, these same components may be dangerous.
And the main problem is that they are not always indicated on the labeling of drugs in pharmacies where they are sold to customers. Thus, the study very clearly demonstrates that even the safest, at first glance, inactive components can be really dangerous and harmful, although for a certain layer of patients with pronounced predispositions or allergies.
It is worth noting that at this stage in the United States this issue was often considered at the highest political level, and most likely very soon the rules for creating, labeling and dispensing medicines in this country will change – and therefore, similar changes may affect the European drug market. Whatever it was, this study provides a lot of food for thought.